Unexpectedly, neither of the two donors had been diagnosed with AD, with one having been diagnosed with PSP and the other being a control donor, thus raising the possibility that Tau species that are immunoreactive with Tau-2 may also be present in the brains of some control donors. This evidence concerns the gene MAPT and Alzheimer disease.